Olema Pharmaceuticals, Inc. (OLMA)
16.48
0.00 (0.00%)
USD |
NASDAQ |
Apr 16, 16:00
16.48
0.00 (0.00%)
After-Hours: 18:39
Olema Pharmaceuticals Cash from Investing (TTM) : -155.76M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| EyePoint Plc | 68.58M |
| CytomX Therapeutics, Inc. | -59.74M |
| Corvus Pharmaceuticals, Inc. | -7.796M |
| Protagonist Therapeutics, Inc. | -49.33M |
| Oric Pharmaceuticals, Inc. | -148.03M |